Tortugas Neuroscience raises $106 million in Seed and Series A funding to advance its clinical stage pipeline targeting neurology disorders, led by Cure Ventures and The Column Group.
Amount Raised
$106 Million
Round Type
Series A
Investors
Description
Tortugas Neuroscience has announced $106 million in funding from Seed and Series A financings to support its research and Phase 2 clinical trials. Led by Cure Ventures, The Column Group, and AN Ventures, the funding aims to expedite novel medicine developments. The company's focus is on treating major neurology and neuropsychiatric disorders. Tortugas features a team of experienced drug developers to deliver innovative treatment solutions.
Quick answer
Tortugas Neuroscience raised $106 Million in a Series A round, dated April 21, 2026. Investors: Cure Ventures, The Column Group and AN Ventures.
- How much did Tortugas Neuroscience raise?
- Tortugas Neuroscience raised $106 Million in a Series A round on April 21, 2026.
- Who invested in Tortugas Neuroscience?
- Cure Ventures, The Column Group and AN Ventures are named as investors in this round.
- What does Tortugas Neuroscience do?
- Tortugas Neuroscience is a neurology-focused biotech company dedicated to developing effective medicines that address diseases of the brain.
- Where is Tortugas Neuroscience based and how big is it?
- Fundz records about 2 employees.
- Who are the decision-makers at Tortugas Neuroscience?
- Fundz holds 1 contact at Tortugas Neuroscience, including the Executive Director, R&D Operations, Program & Alliance Management. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tortugas Neuroscience that raised within 45 days of this round, from Fundz verified event records.
- Goldenrod Therapeutics raised $6.5M (Seed) on June 4, 2026.
- Ona raised $87M (Series B) on June 4, 2026.
- Tolerance Bio raised $15M on June 3, 2026.
- Toregem raised $5.3M on June 2, 2026.
- Tavo Biotherapeutics raised $17M (Series A) on June 2, 2026.
- Hemab Therapeutics raised $347M (IPO) on June 1, 2026.
Who to call at Tortugas Neuroscience, and when
A new round usually means Tortugas Neuroscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tortugas Neuroscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tortugas Neuroscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tortugas Neuroscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tortugas Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTortugas Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.